Feedback

Browsing by A


Use an asterisk (*) for partial word searches (e.g. pemph*)

268 results found.

1.
2.
3.
4.
5.
6.
Ordering Recommendation:   Detect Acanthamoeba spp and Naegleria fowleri in various specimen types.
7.
Ordering Recommendation:   Detect Acanthamoeba spp, Naegleria spp, and other free-living amoebae.
8.
9.
10.
11.
Ordering Recommendation:   Monitor exposure to acetone.
12.
13.
Ordering Recommendation:   Acceptable reflexive panel for diagnosing myasthenia gravis. Panel contains binding, blocking, and modulating antibodies; titin antibody; and SMA IgG screen with titer.
14.
Ordering Recommendation:   Preferred reflexive panel for diagnosing myasthenia gravis. Panel contains binding, blocking, and modulating antibodies.
15.
Ordering Recommendation:   Initial diagnostic testing for myasthenia gravis. For reflexive panel, which contains binding, blocking, and modulating antibodies, refer to Acetylcholine Receptor Antibody Reflexive Panel (2001571).
16.
Ordering Recommendation:   Initial diagnostic testing for myasthenia gravis. For reflexive panel, which contains binding, blocking, and modulating antibodies, refer to Acetylcholine Receptor Antibody Reflexive Panel (2001571).
17.
Ordering Recommendation:   Assessment of clinical activity of and initial diagnostic testing for myasthenia gravis. For reflexive panel, which contains binding, blocking, and modulating antibodies, refer to Acetylcholine Receptor Antibody Reflexive Panel (2001571).
18.
19.
Ordering Recommendation:   Rule out achondroplasia.
20.
Ordering Recommendation:   Rule out achondroplasia.
21.
22.
Ordering Recommendation:   This acid hemolysin (Ham) test is the preferred initial test for the rare genetic disorder, congenital dyserythropoietic anemia type II. This test is considered obsolete for the diagnosis of paroxysmal nocturnal hemoglobinuria. The preferred initial diagnostic test for paroxysmal nocturnal hemoglobinuria is the Paroxysmal Nocturnal Hemoglobinuria (PNH), RBC and WBC (2005006).
23.
24.
25.
26.
27.
28.
29.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
30.
Ordering Recommendation:   Recommended FISH panel for adults with newly diagnosed ALL.
31.
Ordering Recommendation:   Recommended FISH panel for children with newly diagnosed ALL.
32.
Ordering Recommendation:   Use in conjunction with conventional cytogenetics for diagnosis, prognosis, and monitoring of minimal residual disease (MRD) in therapy-related MDS or AML associated with MDS. Use to establish and/or monitor for abnormal clone.
33.
Ordering Recommendation:   Identify prognostically important translocations in newly diagnosed AML.
34.
35.
36.
37.
Ordering Recommendation:   Evaluate response failure to adalimumab therapy. Determine and adjust dosage or identify the need for change to another anti-TNF-alpha inhibitor.
38.
39.
40.
41.
42.
43.
44.
Ordering Recommendation:   Diagnose adenovirus-associated gastroenteritis.
45.
Ordering Recommendation:   Aids in histologic diagnosis of adenovirus.
46.
47.
48.
49.
50.
Ordering Recommendation:   Aids in the diagnosis of adrenal insufficiency and determining the presence of anterior pituitary tumors.
51.
Ordering Recommendation:   Screen, diagnose, and monitor diseases associated with excess or deficient cortisol production.
52.
Ordering Recommendation:   Screen, diagnose, and monitor diseases associated with excess or deficient cortisol production.
53.
Ordering Recommendation:   Screen, diagnose, and monitor diseases associated with excess or deficient cortisol production.
54.
55.
Ordering Recommendation:   This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787 x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.
56.
57.
58.
59.
Ordering Recommendation:   Preferred test to confirm suspected agammaglobulinemia in individual with clinical symptoms.
60.
Ordering Recommendation:   Refer to Additional Technical Information document.
61.
62.
63.
64.
65.
66.
67.
68.
Ordering Recommendation:   Useful in the assessment of acute ethanol exposure. Ethyl Glucuronide Screen with Reflex to Confirmation, Urine (2007912) is preferred for the assessment of ethanol exposure up to several days post-exposure.
69.
Ordering Recommendation:   Use to identify ethanol, methanol, isopropanol or acetone ingestion.
70.
Ordering Recommendation:   Do not use as a stand-alone test. This non-specific test has been replaced by more specific markers for muscle or liver damage. It has largely been replaced by other enzyme tests such as CK, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) as markers of muscle or liver damage.
71.
Ordering Recommendation:   Use in aldosterone suppression or loading testing.
72.
Ordering Recommendation:   Use in aldosterone suppression or stimulation testing.
73.
Ordering Recommendation:   Diagnose and screen for primary hyperaldosteronism.
74.
Ordering Recommendation:   The combined aldosterone/renin tests are preferred (refer to Aldosterone/Renin Activity Ratio (0070073) or Aldosterone and Renin, Direct with Ratio (2002582)) for diagnosing hyperaldosteronism.
75.
Ordering Recommendation:   For screening and diagnosing for primary hyperaldosteronism, order this urine test concurrently with the serum renin testing (refer to Renin Activity (0070105)).
76.
Ordering Recommendation:   Diagnose and screen for primary hyperaldosteronism.
77.
Ordering Recommendation:   Determine eligibility for tyrosine kinase inhibitor (TKI) therapy, primarily in individuals with pulmonary adenocarcinomas. Test detects ALK fusion proteins (IHC) and gene rearrangements (FISH) in solid tumors.
78.
Ordering Recommendation:   Determine eligibility for tyrosine kinase inhibitor (TKI) therapy, primarily in individuals with pulmonary adenocarcinomas. Test detects ALK fusion proteins.
79.
Ordering Recommendation:   Screening test for all ALK fusions. Use this test especially if the companion diagnostic test for crizotinib is required.
80.
81.
82.
83.
84.
Ordering Recommendation:   Prenatal diagnosis of ONTD at 14-25 weeks gestation.
85.
86.
Ordering Recommendation:   Surveillance and monitoring in hepatocellular carcinoma; test is less specific than one which includes AFP-L3 isoform.
87.
Ordering Recommendation:   Surveillance and monitoring of hepatocellular carcinoma.
88.
Ordering Recommendation:   Preferred first-tier genetic test for confirmation of suspected alpha thalassemia or alpha thalassemia trait. Detects common, rare and novel deletions or duplications of the alpha globin gene cluster.
89.
Ordering Recommendation:   Commonly used as a second-tier test for detection of alpha thalassemia and REQUIRES PERMISSION from ARUPs Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial screening test is Alpha Globin (HBA1 and HBA2) Deletion/Duplication (2011622).
90.
Ordering Recommendation:   Comprehensive test for detection of alpha thalassemia or alpha thalassemia trait.
91.
92.
Ordering Recommendation:   Acceptable first-tier genetic test for confirmation of suspected alpha thalassemia or alpha thalassemia trait. Assesses for seven common alpha globin gene deletions.
93.
94.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
95.
Ordering Recommendation:   Determines AAT enzyme plasma concentration for the initial evaluation of A1AT deficiency.
96.
Ordering Recommendation:   Aids in histologic diagnosis of Alpha-1-Antitrypsin deficiency.
97.
Ordering Recommendation:   Diagnostic testing for alpha-1-antitrypsin deficiency or carrier screening for alpha-1-antitrypsin deficiency.
98.
99.
Ordering Recommendation:   Determine specific AAT protein variant(s) in individual with decreased concentration of AAT (<90mg/dL).
100.
101.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
102.
103.
104.
105.
Ordering Recommendation:   Enzyme testing is reliable for diagnosing Fabry disease in males; it does not detect carriers. For carrier status, DNA analysis is recommended.
106.
Ordering Recommendation:   Use to diagnose patients for mucopolysaccharidosis type I (also known as MPS I, Hurler, Scheie, and Hurler-Scheie syndromes). To screen for all types of MPS, refer to Mucopolysaccharides Screen - Electrophoresis & Quantitation, Urine (0081352). To monitor glycosaminoglycans (GAGs) in patients previously diagnosed with MPS, refer to Mucopolysaccharides, Quantitative, Urine (0081357).
107.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
108.
Ordering Recommendation:   This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.
109.
Ordering Recommendation:   Acceptable first-line genetic test for the detection of mutations causing X-linked Alport syndrome.
110.
Ordering Recommendation:   Diagnostic testing for X-linked Alport syndrome. Carrier screening for X-linked Alport syndrome. Predictive testing for X-linked Alport syndrome.
111.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
112.
113.
114.
115.
116.
117.
118.
119.
120.
Ordering Recommendation:   Screen for disorders of amino acids transport (eg, cystinuria, lysinuric protein intolerance, HHH syndrome). Also useful to evaluate renal tubular function.
121.
Ordering Recommendation:   Evaluate suspected aminolevulinic acid dehydratase deficiency (ADP) porphyria, or hereditary tyrosinemia.
122.
Ordering Recommendation:   Confirm a diagnosis of aminolevulinic acid dehydratase deficiency porphyria (ADP), an extremely rare porphyria.
123.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
124.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
125.
126.
127.
128.
Ordering Recommendation:   Detect Acanthamoeba spp, Naegleria fowleri and other free-living amoebae.
129.
130.
131.
132.
Ordering Recommendation:   Detect exposure to amphetamines.
133.
134.
Ordering Recommendation:   Consider ordering in individuals with stiff-person syndrome, paraneoplastic encephalomyelitis (PEM), and sensory neuronopathy (SN). May aid in diagnosis of occult tumor, recurrence of tumor, or second tumor.
135.
136.
137.
138.
139.
Ordering Recommendation:   Use to confirm the clinical diagnosis of amyotrophic lateral sclerosis (ALS).
140.
141.
142.
143.
144.
Ordering Recommendation:   Acceptable test for acute or convalescent phase of infection from Anaplasma phagocytophilium. May be useful when PCR testing is not an option (eg, outside the 2 week window for acute phase). However, PCR testing is generally preferred; refer to Tick-Borne Disease Panel by PCR, Blood (2008670) or Ehrlichia and Anaplasma Species by Real-Time PCR (2007862).
145.
Ordering Recommendation:   Most useful to detect antibodies during convalescent phase. PCR testing is preferred; refer to Tick-Borne Disease Panel by PCR, Blood (2008670) or Ehrlichia and Anaplasma Species by Real-Time PCR (2007862).
146.
Ordering Recommendation:   Most useful to detect antibodiesl during acute phase of disease; recommend concurrent testing with IgG A. phagocyophilium. PCR testing is preferred; refer to Tick-Borne Disease Panel by PCR, Blood (2008670) or Ehrlichia and Anaplasma Species by Real-Time PCR (2007862).
147.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
148.
Ordering Recommendation:   Preferred reflex panel for the workup of suspected vasculitis. Panel detects ANCA, MPO, and PR-3 antibodies. For patients with a history of vasculitis, refer to Anti-Neutrophil Cytoplasmic Antibody with Reflex to Titer and MPO/PR-3 Antibodies (2002068) or Serine Protease 3 Antibody (0050527) or Myeloperoxidase Antibody (0050526) tests.
149.
Ordering Recommendation:   Not generally recommended. Adjunct tool for the evaluation of hirsutism.
150.
Ordering Recommendation:   Aids in the investigation of virilizing endocrinopathies and in managing congenital adrenal hyperplasia in conjunction with other sex steroids. Not recommended for initial evaluation of polycystic ovarian syndrome.
151.
152.
Ordering Recommendation:   Second tier test for the diagnosis of Angelman syndrome. Order if suspicion for Angelman syndrome remains after normal methylation analysis. For first-tier testing, refer to Angelman Syndrome and Prader-Willi Syndrome by Methylation (2005077).
153.
Ordering Recommendation:   Preferred initial diagnostic test for Angelman syndrome or Prader-Willi syndrome.
154.
Ordering Recommendation:   Prenatal testing for Angelman syndrome or Prader-Willi syndrome. Identifies cases resulting from molecular mechanisms that produce abnormal methylation patterns.
155.
156.
157.
158.
Ordering Recommendation:   May assist in the diagnosis of ankylosing spondylitis, juvenile rheumatoid arthritis, and Reiter's syndrome. This test is not diagnostic for these disorders and should be correlated with other clinical signs and symptoms. Flow cytometry (0095840) is the preferred test for most patients since its sensitivity and specificity are nearly equivalent to the HLA-B27 PCR genotyping test.
159.
Ordering Recommendation:   Assess risk for lupus nephritis and global SLE disease activity.
160.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
161.
Ordering Recommendation:   Use prior to transfusion or in possible transfusion reactions to determine the presence of anti-IgA antibodies in patients with selective IgA deficiency.
162.
163.
Ordering Recommendation:   Preferred panel for evaluating and managing individuals with a known diagnosis of vasculitis. Preferred reflex panel for the workup of suspected vasculitis is ANCA-Associated Vasculitis Profile (ANCA/MPO/PR-3) with Reflex to ANCA Titer (2006480).
164.
Ordering Recommendation:   Use as an adjunct diagnostic tool to differentiate ulcerative colitic from Crohn disease.
165.
Ordering Recommendation:   Aids in initial diagnosis of connective tissue disease.
166.
Ordering Recommendation:   Aids in initial diagnosis of connective tissue disease.
167.
Ordering Recommendation:   For the differential diagnosis of connective tissue diseases.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.
201.
202.
203.
204.
205.
206.
207.
208.
209.
210.
211.
212.
213.
214.
215.
Ordering Recommendation:   Acceptable second-line test when antiphospholipid syndrome (APS) is strongly suspected and aPL criteria tests are negative.
216.
Ordering Recommendation:   Preferred initial panel for strong suspicion of antiphospholipid syndrome (APS).
217.
Ordering Recommendation:   Order to detect and subtype antithrombin deficiency.
218.
Ordering Recommendation:   Not recommended as an initial test to detect antithrombin (AT) deficiency. Use to determine subtype in AT-deficient individuals.
219.
Ordering Recommendation:   Recommended test to detect antithrombin deficiency.
220.
Ordering Recommendation:   Screen for HSV infection suspected to be acyclovir resistant.
221.
Ordering Recommendation:   Screen for HSV infection suspected to be foscarnet resistant.
222.
Ordering Recommendation:   This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.
223.
Ordering Recommendation:   Preferred panel for individuals with clinical phenotype of aortic/vascular aneurysm, dissection, or rupture.
224.
Ordering Recommendation:   Acceptable panel for individuals with clinical phenotype of aortic/vascular aneurysm, dissection, or rupture.
225.
Ordering Recommendation:   Acceptable initial test to detect activated protein C resistance due to a factor V Leiden mutation. Preferred test is APC Resistance Profile with Reflex to Factor V Leiden (0030192). However, Factor V Leiden (F5) R506Q Mutation (0097720) is the preferred initial test for individuals with supratherapeutic concentrations of heparin, direct thrombin inhibitors, extreme factor V deficiency, or lupus anticoagulants with markedly prolonged baseline clotting times.
226.
Ordering Recommendation:   Recommended test to detect activated protein C resistance and confirm presence of a factor V Leiden mutation.
227.
Ordering Recommendation:   Not recommended for cardiovascular disease risk assessment. Use to detect the very rare familial alpha-lipoprotein deficiency.
228.
Ordering Recommendation:   Acceptable non-traditional secondary cardiovascular disease risk screen for specific populations.
229.
Ordering Recommendation:   Detects suspected familial defective APOB-100 mutations in hypercholesterolemic individuals.
230.
Ordering Recommendation:   Not usually recommended for cardiovascular disease risk assessment.
231.
Ordering Recommendation:   Use to detect APOE mutations in individuals with a suspicion of type III hyperlipoproteinemia (familial hyperlipoproteinemia).
232.
Ordering Recommendation:   Aids in evaluation of neuromyelitis optica (NMO) and NMO spectrum disorders.
233.
Ordering Recommendation:   Use in conjunction with serum autoantibody tests to diagnose neuromyelitis optica (NMO).
234.
Ordering Recommendation:   West Nile Virus serology is the only remaining component of this panel available in the U.S. Refer to West Nile testing for IgG & IgM, CSF (0050228). See Inactivation Notification.
235.
Ordering Recommendation:   West Nile Virus serology is the only remaining component of this panel available in the U.S. Refer to West Nile testing for IgG & IgM, Serum (0050226). See Inactivation Notification.
236.
Ordering Recommendation:   West Nile Virus serology is the only remaining component of this panel available in the U.S. Refer to West Nile testing for IgG, CSF (0050238). See Inactivation Notification.
237.
Ordering Recommendation:   West Nile Virus serology is the only remaining component of this panel available in the U.S. Refer to West Nile testing for IgG, Serum (0050234). See Inactivation Notification.
238.
Ordering Recommendation:   West Nile Virus serology is the only remaining component of this panel available in the U.S. Refer to West Nile testing for IgM, CSF (0050239). See Inactivation Notification.
239.
Ordering Recommendation:   West Nile Virus serology is the only remaining component of this panel available in the U.S. Refer to West Nile testing for IgM, Serum (0050236). See Inactivation Notification.
240.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
241.
242.
Ordering Recommendation:   Preferred molecular genetic test following biochemical testing suggestive of arginine:glycine amidinotransferase (AGAT) deficiency.
243.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
244.
245.
Ordering Recommendation:   Refer to Additional Technical Information document.
246.
247.
248.
249.
250.
251.
252.
253.
Ordering Recommendation:   This test is used for detecting 3 common BRCA1 and BRCA2 mutations prevalent in individuals of Ashkenazi Jewish descent and REQUIRES PERMISSION from ARUPs Genetic Counselor (800-242-2787, x2141) before ordering. Preferred comprehensive test is Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing and Deletion/Duplication (2011949) or Familial Mutation, Targeted Sequencing (2001961) if a familial mutation is known.
254.
Ordering Recommendation:   Carrier screening for genetic disorders common in Ashkenazi Jewish individuals.
255.
256.
257.
258.
Ordering Recommendation:   Aspergillus fumigatus-specific IgG is one component of testing recommended to establish the diagnosis of allergic bronchopulmonary aspergillosis (ABPA); it is not appropriate for diagnosing invasive aspergillosis.
259.
260.
261.
262.
263.
264.
Ordering Recommendation:   Preferred molecular test for ATP7A-related copper transport disorders.
265.
Ordering Recommendation:   Acceptable test to confirm diagnosis of Menkes disease, occipital horn syndrome and ATP7A-related distal motor neuropathy; detects most pathogenic ATP7A gene mutations but does not detect deletions and duplications.
266.
Ordering Recommendation:   This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.
267.
Ordering Recommendation:   Initial test in conjunction with ANCA-associated vasculitis profile for evaluation of autoimmune liver disease.
268.